Macroplastique Gets FDA Go-Ahead Following Warning Letter Resolution
This article was originally published in The Gray Sheet
Executive Summary
Uroplasty's Macroplastique urinary incontinence bulking agent secured PMA approval Oct. 30 and will launch in the U.S. early in 2007 now that the firm has resolved an FDA warning letter